| Pharmaceutical active ingredients: |
| Levomoprolol HydrochlorideMebutizide |
| Available forms, composition and doses of Minusten: |
| N / A |
| Minusten medical category: |
| Human:Anti-hypertensives agentsBeta-blockers |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AA13 - Mebutizide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Zambon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Laam | Levomethadyl Acetate | Unidentified Pharmaceutical Company |
| Nor-Laam | Levomethadyl Acetate | Unidentified Pharmaceutical Company |
| OrLAAM | Levomethadyl Acetate Hydrochloride | Roxane Laboratories; Britannia Pharmaceuticals; Newport Pharmaceuticals; Niche Pharma; Sipaco Internacional |
| Levotensin | Levomoprolol Hydrochloride | Simes |
| Betalevo | Levomoprolol Hydrochloride; Mebutizide | Simes |
| Neo-Cobefrin | Levonordefrin | Unidentified Pharmaceutical Company |
| Arestocaine with Levonordefrin | Levonordefrin Hydrochloride; Mepivacaine Hydrochloride | Solvay; Carlisle Laboratories |
| Carbocaine; Neo-Cobefrin | Levonordefrin Hydrochloride; Mepivacaine Hydrochloride | Kodak; Carestream Health |
| Mepivacaine; Levonordefrin | Levonordefrin Hydrochloride; Mepivacaine Hydrochloride | Graham Chemical Corporation |
| Scandonest with Levonordefrin | Levonordefrin Hydrochloride; Mepivacaine Hydrochloride | Novocol Pharmaceutical |